Zobrazeno 1 - 10
of 58
pro vyhledávání: '"J Wong"'
Publikováno v:
Cancer. 127:45-55
Patients from rural and low-income households may have suboptimal access to liver disease care, which may translate into worse HCC outcomes. The authors provide a comprehensive update of HCC incidence and outcomes among US adults, focusing on the eff
Autor:
Sean McBride, Jatin P. Shah, Marc Cohen, Richard J. Wong, Alan L. Ho, Benjamin R. Roman, Ashok R. Shaha, Lara Dunn, Jung Julie Kang, Jay O. Boyle, Daphna Y. Gelblum, James Vincent Fetten, Bhuvanesh Singh, Kaveh Zakeri, Snehal G. Patel, C. Jillian Tsai, Nadeem Riaz, Linda Chen, Alisa Rybkin, Luc G. T. Morris, Erin F. Gillespie, Ian Ganly, David G. Pfister, Yao Yu, Eric J. Sherman, Nancy Y. Lee, Jennifer R. Cracchiolo
Publikováno v:
Cancer
Because of the national emergency triggered by the coronavirus disease 2019 (COVID‐19) pandemic, government‐mandated public health directives have drastically changed not only social norms but also the practice of oncologic medicine. Timely head
Autor:
S. Kitpanit, Sean McBride, Ming Fan, Ian Ganly, Bhuvanesh Singh, Nancy Y. Lee, Pamela Fox, Chiaojung Jillian Tsai, Anna Lee, Eric J. Sherman, Nadeem Riaz, Loren S. Michel, Jay O. Boyle, Dan Fan, Richard J. Wong, Jung Julie Kang, Huili Wang, Kevin Sine, Dennis Mah, Lara Dunn, Marc Cohen
Publikováno v:
Cancer. 126:1905-1916
BACKGROUND Proton therapy (PT) improves outcomes in patients with nasal cavity (NC) and paranasal sinus (PNS) cancers. Herein, the authors have reported to their knowledge the largest series to date using intensity-modulated proton therapy (IMPT) in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrew G. Shuman, Ralph W. Gilbert, Eric Monteiro, Anthony C. Nichols, Eric M. Genden, David P. Goldstein, Andrew J. Rosko, Ehab Y. Hanna, John R. de Almeida, David Forner, Caitlin McMullen, Evan M. Graboyes, Vasu Divi, Richard J. Wong, Han Zhang, Ian J. Witterick, Marc Cohen, Carol M. Lewis, Brett A. Miles, Danny Enepekides, Vinidh Paleri, Patrick J. Gullane, Dale Brown, Douglas B. Chepeha, Antoine Eskander, Kevin Higgins, Jeffrey N. Myers, Christopher W. Noel, Jonathan C. Irish
Publikováno v:
Cancer
Background In the wake of the coronavirus disease 2019 (COVID‐19) pandemic, access to surgical care for patients with head and neck cancer (HNC) is limited and unpredictable. Determining which patients should be prioritized is inherently subjective
Autor:
Karen Kelly, Isabell Speit, Janice M. Mehnert, Anja H. Loos, Nicholas Iannotti, Helga Koch, Manish R. Patel, Deborah J. Wong, James L. Gulley, Matthew H. Taylor, Jeffrey R. Infante
Publikováno v:
Cancer. 124:2010-2017
Author(s): Kelly, Karen; Infante, Jeffrey R; Taylor, Matthew H; Patel, Manish R; Wong, Deborah J; Iannotti, Nicholas; Mehnert, Janice M; Loos, Anja H; Koch, Helga; Speit, Isabell; Gulley, James L | Abstract: BackgroundAntibodies targeting the program
Autor:
Michele M. Tana, John Ha, Maria Aguilar, Melissa Yan, Robert G. Gish, Benny Liu, Robert J. Wong, Taft Bhuket
Publikováno v:
Cancer. 122:2512-2523
BACKGROUND Hepatocellular carcinoma (HCC) is one of the fastest rising causes of cancer-related deaths in the United States, with disparities observed in cancer incidence and survival between ethnic groups. This report provides updated analyses on ra
Autor:
Karen, Kelly, Jeffrey R, Infante, Matthew H, Taylor, Manish R, Patel, Deborah J, Wong, Nicholas, Iannotti, Janice M, Mehnert, Anja H, Loos, Helga, Koch, Isabell, Speit, James L, Gulley
Publikováno v:
Cancer
BACKGROUND Antibodies targeting the programmed death‐ligand 1 (PD‐L1)/programmed cell death protein 1 (PD‐1) checkpoint may cause adverse events (AEs) that are linked to the mechanism of action of this therapeutic class and unique from those ob
Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
Autor:
Allen S. Ho, Luc G. T. Morris, Ian Ganly, Louise Davies, Iain J. Nixon, Snehal G. Patel, Frank L. Palmer, Laura Y. Wang, R. Michael Tuttle, Richard J. Wong
Publikováno v:
Cancer. 121:1793-1799
BACKGROUND Survival rates are commonly used to measure success in treating cancer, but can be misleading. Modern diagnostic practices can lead to the appearance of improving cancer survival, as tumors are diagnosed earlier (lead-time bias) or as an i